Effective Q1 2027, our company, formerly known as Zeptide Pharma (and operating under the name Tirzepatide Pharma) will officially rebrand as MayMag Biologics. This strategic transition establishes a distinct corporate identity and eliminates market confusion between our company and the active pharmaceutical ingredient (API) generically known as Tirzepatide.

Download our Catalog & Price Sheet here.
Partner with a premier GMP Certified outsourcing facility for high-purity peptides. We provide cGMP-compliant sterile peptidesto ensure the highest safety and quality for your clinic’s needs. View our peptide catalog today!
Streamline your business with bulk peptides from a trusted cGMP manufacturer. We specialize in Pharma-grade and RUO Peptides, offering reliable supply chains and rigorous third-party testing for nationwide distribution.
Looking for pharmaceutical-grade peptides? Our sterile injectable manufacturing facility follows strict cGMP guidelines to deliver high-potency, verified peptides for medical and research applications. Request a quote for bulk orders.
Access high-demand wellness peptides from a leading sterile peptide manufacturer. We provide office-stock medications including GLP-1s and more, produced in our state-of-the-art FDA-inspected facility.

Welcome to MayMag Biologics, the industry-leading manufacturer dedicated exclusively to developing and producing sterile glaucoma treatments. We specialize in formulating high-quality, reliable, and accessible ophthalmic solutions designed to effectively manage intraocular pressure (IOP) and preserve vision for patients worldwide.
As a trusted partner for healthcare providers, pharmacies, and pharmaceutical wholesalers, Zeptide Pharma sets the gold standard in sterile ophthalmic manufacturing.
At MayMag Biologics, we understand that every patient's needs are unique. That is why our state-of-the-art sterile manufacturing facilities produce a comprehensive pipeline of advanced glaucoma eye drops and therapies across all major drug classes:

Download our Catalog & Price Sheet here.
We provide B2B procurement teams and compounding manufacturers with comprehensive oversight of the evolving pharmaceutical landscape. Our team monitors the shifting regulatory frameworks governing Active Pharmaceutical Ingredients (APIs), including FDA Section 503A bulk drug substance evaluations.
By tracking substances as they transition between FDA Categories 1 and 2, we support your organization’s risk assessment, vendor qualification, and supply continuity planning. We specialize in providing high-purity, human-grade APIs for research and development, ensuring all documentation and availability align with current jurisdictional requirements. As the regulatory status of key peptides evolves, we ensure your laboratory or manufacturing facility is prepared for upcoming market shifts and expanded sourcing opportunities.
For over 25 years, we have been a trusted cornerstone in the industry, reliably supplying high-quality generic medicines to government awardees and driving healthcare accessibility on a global scale.
.
Operating as an advanced Investigational New Drug (IND) facility, MayMag Biologics stands at the forefront of pharmaceutical innovation, actively developing biosimilar generics and cutting-edge Oral GLP-1 therapeutics. Our robust manufacturing infrastructure is engineered for scale, seamlessly producing insulin pens, nasal sprays, advanced weight-loss treatments, and specialized ophthalmology products for international markets.
.
Bacteriostatic Water for Injection (BWFI) is a crucial component in modern medicine, used to dilute or dissolve medications for injection. Unlike regular sterile water, bacteriostatic water contains exactly 0.9% benzyl alcohol, which acts as a preservative to halt the growth of most potentially contaminating bacteria. This allows vials to be safely re-entered multiple times for multi-dose applications.


MayMag Biologics (formerly Zeptide Pharma) is a USA-based large-scale industrial manufacturer of insulin pens, anti-inflammatory auto pens, insulin nasal sprays, weight loss, and ophthalmology products

An IND outsourcing Facility for the development of once-a-week oral GLP1, generic diabetic biosimilars, Bacteriostatic Water, lyophilized peptides, and generic drug manufacturer.

Our expertise spans a diversified portfolio of injectable and solid dose medications, supported by dependable international distribution

Our vial products undergo a meticulous sterilization and filtration process, using a 0.22-micron PES-layered vacuum filter and a 2000ml Foxx Life Sciences Autofil assembly. Each batch ensures your buffer water is filtered into sterile containers, adhering to the highest laboratory standards. Choose products where every detail counts and your peace of mind is guaranteed—start now with our uncompromising filtration solutions.

MayMag Biologics (Formerly Zeptide Pharma)-Be assured, the name change is strictly a rebranding effort. Our customers and industry partners can expect a seamless transition with uninterrupted supply chains, consistent manufacturing processes, and the exact same rigorous quality control standards.

We facilitate the cGMP manufacture and global supply of finished drug products to premier markets, including North America, Europe, Asia, and the Middle East. Our commitment to compliance is validated by a flawless track record of inspections from the world’s most stringent global regulatory authorities, including:

Copyright © 2026 GLP1 Tide Manufacturer - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.